Crystal-Storing Histiocytosis as a Red Herring in Multiple Myeloma

Avik Basu1, Asish Rath1, Sushant Vinarkar2

  • 1Department of Laboratory Hematology, Tata Medical Center, 14 Main Arterial Road (EW), Newtown, Rajarhat, Kolkata, 700156 India.

Insights

This case report details an extremely rare instance of multiple myeloma (MM) coexisting with crystal-storing histiocytosis (CSH) and amyloidosis in a single patient. Recognizing CSH is crucial as it can mask underlying plasma cell disorders.

Area of Science:

  • Hematology
  • Oncology
  • Pathology

Background:

  • Multiple myeloma (MM) is a plasma cell disorder causing organ damage via immunoglobulin deposition.
  • Crystal-storing histiocytosis (CSH) is a rare condition where paraproteins crystallize within histiocytes.
  • The simultaneous occurrence of MM, CSH, and amyloidosis is exceptionally uncommon.

Purpose of the Study:

  • To report a unique case of a 56-year-old male with the rare triad of MM, CSH, and amyloidosis.
  • To highlight the diagnostic challenges posed by CSH, which can obscure the underlying plasma cell neoplasm.
  • To emphasize the importance of comprehensive evaluation in patients with suspected paraprotein dyscrasias.

Main Methods:

  • Clinical presentation of a patient with chronic low back pain and elevated creatinine.
  • Laboratory investigations including M-band, free light chain ratio, and immunoglobulin levels.
  • Bone marrow aspirate and biopsy with morphological examination, immunohistochemistry (CD138, CD68, CD163, S-100), and Congo red staining for amyloid detection.

Main Results:

  • The patient presented with symptoms and laboratory findings consistent with MM.
  • Bone marrow examination revealed plasma cells and histiocytes containing cytoplasmic crystals (CSH).
  • Amyloid deposits were identified in blood vessels, confirming amyloidosis. The patient achieved very good partial response (VGPR) with bortezomib-based chemotherapy.

Conclusions:

  • This case underscores the diagnostic significance of CSH, which can mimic other conditions and lead to underestimation of plasma cell burden.
  • The co-presentation of MM, CSH, and amyloidosis represents a rare but critical diagnostic challenge in hematologic pathology.
  • Early recognition and appropriate chemotherapy are vital for managing this complex paraprotein-related disorder.